Apple's Vision Pro headset is set to shake up the reality technology market. The initial buzz has died down, so now seems a good time to take a closer look at the potential beneficiaries of this new product category.

>> Read more

Thanks to technological advances, medical insight into the human body is becoming increasingly precise, facilitating the early diagnosis of diseases. Endoscopes and diagnostic test systems make a significant contribution to this progress. The industry is characterised by a high rate of innovation, developing products that help to treat patients quickly and gently. The pace of innovation is likely to remain above average in the future.

>> Read more

The Swiss stock market heavyweights Nestlé, Novartis and Roche together account for half of the weightings of the Swiss Market Index. The relative stability of these stocks makes them popular underlyings for defensive yield enhancement products.

>> Read more

Yield enhancement products are often structured with worst-of baskets. In the case of (barrier) reverse convertibles, however, it can be quite attractive to select a single underlying - although this reduces the yield, it also reduces the probability that a strike or barrier will be undershot.

>> Read more

Ongoing industrialization and population growth are resulting in continuously increasing demand for natural resources. A large proportion of the goods we manufacture still wind up in landfill sites or incinerators after use. In product manufacturing, the closing of the material flow cycle is of central importance. Natural resources can be divided into renewables and non-renewables. From a sustainability perspective, the increased use of renewable resources should be favored

>> Read more

With Low Strike BRC the strike that must be reached in the event of a barrier being touched is below the initial fixing. If such a barrier event occurs, the probability that all underlying prices will be above the strike at the end of the term is higher.

>> Read more

2023 has not been a veray exciting year on the Swiss stock market so far. The SMI® is up a good 3.5% (ytd), while the Swiss Performance Index®, which includes most of the remaining Swiss stocks in addition to the heavyweights from the leading index, is up about 6%. However, not all constituents of these indices can show positive performance. The shares of large corporations such as Roche and Zurich, as well as those of smaller companies, are trading below their prices at the beginning of the year. Nevertheless - or maybe because of this - favorable opportunities are emerging.

>> Read more

Insurance stocks are popular underlyings for structured products, especially for yield enhancement products. With derivatives from Zürcher Kantonalbank, investors benefit not only from attractive conditions, but also from our bank's excellent rating.

>> Read more

Shark notes owe their interesting name to their payoff profile, which resembles the dorsal fin of a shark. They belong to the group of capital protection products and offer investors a participation in the price development of an underlying, while the invested capital is protected against loss. This reduces the risk of loss compared to a direct investment in the underlying, while at the same time allowing participation in the upward movement.

>> Read more

The world's largest companies are not based in Europe, but direct their activities from the other side of the Atlantic and are listed on the American stock exchanges. If investors from Switzerland invest in this market, they have to take into account possible exchange rate fluctuations in addition to the price risk, but they benefit from the higher interest rate - an important factor for the profile of yield-optimization products; with similar volatilities, the coupons rise with interest rates.

>> Read more